Varian Medical Systems, Inc. (VAR)

Notice is hereby given that Faruqi & Faruqi, LLP has filed a class action lawsuit in the United States District Court for the Northern District of California, Case No. 4:20-cv-06266-YGR on behalf of shareholders of Varian Medical Systems, Inc. (“Varian” or the “Company”) (NYSE:VAR) who have been harmed by Varian’s and its board of directors’ (the “Board”) alleged violations of Sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) in connection with the proposed merger of the Company with Siemens Healthineers AG (the “Proposed Transaction”). 

On August 2, 2020, the Board caused the Company to enter into an agreement and plan of merger under which Varian shareholders stand to receive $177.50 in cash for each share of Varian stock they own.

The complaint alleges that the Form PREM14A Preliminary Proxy Statement filed with the Securities and Exchange Commission violates Sections 14(a) and 20(a) of the Exchange Act because it provides materially incomplete and misleading information about the Company and the Proposed Transaction, including information concerning the Company’s financial projections and analysis, on which the Board relied to recommend the Proposed Transaction as fair to Varian shareholders. 

If you wish to obtain information concerning this action, you can do so by completing the form below 

If you wish to serve as lead plaintiff, you must move the Court no later than November 23, 2020.  Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.